Investors & Media

Overview

Webcast ImageWebcast
Piper Jaffray 28th Annual Healthcare Conference (Replay)
11/29/16 at 12:00 p.m. ET
Piper Jaffray 28th Annual Healthcare Conference
Tuesday, November 29, 2016 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
ENA 2016 Conference Call (Replay)
12/01/16 at 8:00 a.m. ET
ENA 2016 Conference Call
Thursday, December 1, 2016 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
bluebird bio ASH Event (Replay)
12/05/16 at 8:30 p.m. PT
bluebird bio ASH Event
Monday, December 5, 2016 8:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. The company’s objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

stock quote

NASDAQ: BLUE (common stock)

Refresh Quote
ExchangePriceChange (%)Volume
NASDAQ GS (US Dollar)
$72.15
 Stock is Up 2.40 (3.44%)
1,335,832
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Contact

Manisha Pai

Sr. Director, Investor Relations

(617) 245-2107

investor@bluebirdbio.com


Media Contacts

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com


Dan Budwick

Senior Vice President, Media Relations

Pure Communications Inc.

(973) 271-6085

dan@purecommunicationsinc.com